Follow
ISR Immune System Regulation Holding AB
Nasdaq First North GM (Sweden)
ISR Immune System Regulation Holding AB is a Sweden based company is engaged in research within the area of immunotherapy. It is principally focused on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections. The group is focused on developing ISR048 technology for the novel treatment of viral infected patients with a focus on human immunodeficiency virus (HIV) infection.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Exercise
Price
2.90 SEK
Exercise period(s)
24 Feb - 10 Mar 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
ISR
SE0008212195
Nasdaq First North GM
Sweden (SE)
Details of share in ISR Immune System Regulation Holding AB with ticker ISR
Status
Active
Order book id
Amount of instruments
24 718 132
Par value
Currency
SEK
Segment
First North
Type
Price
Pre-money valuation
Time
Files
Listing
24 Mar 2017
Direct listing of ISR Immune System Regulation Holding AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Private placement
5.50 SEK
101.75M SEK
13 Nov 2018
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.50 SEK
101.75M SEK
26 Nov - 11 Dec 2018
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.90 SEK
71.68M SEK
15 May - 29 May 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Remuneration issue
3.33 SEK
164.62M SEK
10 Jun 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Remuneration issue
3.33 SEK
172.56M SEK
12 Jun 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
5.00 SEK
260.66M SEK
29 Jun 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Exercise
2.90 SEK
71.68M SEK
24 Feb - 10 Mar 2021
Option exercise terms for ISR TO1
Type
Ticker
ISIN
Market
OPTION
ISR TO2
SE0014401774
Nasdaq First North GM
Sweden (SE)
Details of option in ISR Immune System Regulation Holding AB with ticker ISR TO2
Status
Active
Order book id
199374
Amount of instruments
8 239 377
Currency
SEK
Trading period
10 Jul 2020 - 16 Nov 2021
Terms
One (1) warrant of series TO 2 entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during ten (10) trading days before the exercise period begins, from October 25, 2021 until November 5, 2021. However, the subscription price can not be lower than SEK 2.90. The exercising period with the support of warrants of series TO 2 will take place from November 9, 2021 until November 23, 2021.
Update (17.06.2020): Conversion of paid subscribed units (BTU) into shares and warrants of series TO 1 and TO 2.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.90 SEK
09 Nov - 23 Nov 2021
Option exercise terms for ISR TO2
Type
Ticker
ISIN
Market
SHARE
ISR
SE0008212195
Nasdaq First North GM
Sweden (SE)
Details of share in ISR Immune System Regulation Holding AB with ticker ISR
Status
Active
Order book id
Amount of instruments
24 718 132
Par value
Currency
SEK
Segment
First North
Type
Price
Pre-money valuation
Time
Files
Listing
24 Mar 2017
Direct listing of ISR Immune System Regulation Holding AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Private placement
5.50 SEK
101.75M SEK
13 Nov 2018
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.50 SEK
101.75M SEK
26 Nov - 11 Dec 2018
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.90 SEK
71.68M SEK
15 May - 29 May 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Remuneration issue
3.33 SEK
164.62M SEK
10 Jun 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Remuneration issue
3.33 SEK
172.56M SEK
12 Jun 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Price
Pre-money valuation
Time
Files
Private placement
5.00 SEK
260.66M SEK
29 Jun 2020
Share issue in ISR Immune System Regulation Holding AB
Type
Ticker
ISIN
Market
OPTION
ISR TO1
SE0014401766
Nasdaq First North GM
Sweden (SE)
Details of option in ISR Immune System Regulation Holding AB with ticker ISR TO1
Status
Archived
Order book id
199373
Amount of instruments
8 239 377
Currency
SEK
Trading period
10 Jul 2020 - 03 Mar 2021
Terms
One (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during ten (10) trading days before the exercise period begins, from February 9, 2021 until February 22, 2021. However, the subscription price can not be lower than SEK 2.90 and no higher than SEK 8.70. The exercising period with the support of warrants of series TO 1 will take place from February 24, 2021 until March 10, 2021.
Update (17.06.2020): Conversion of paid subscribed units (BTU) into shares and warrants of series TO 1 and TO 2.
Update (23.02.2021): The subscription price for the exercise of warrants of series TO1 in ISR has been set at SEK 2.90 per share.
Update (24.02.2021): The exercise period for warrants of series TO1 in ISR begins today.
Update (01.03.2021): Last day for trading in warrants of series TO1 in ISR.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.90 SEK
71.68M SEK
24 Feb - 10 Mar 2021
Option exercise terms for ISR TO1
Type
Ticker
ISIN
Market
OPTION
ISR TO2
SE0014401774
Nasdaq First North GM
Sweden (SE)
Details of option in ISR Immune System Regulation Holding AB with ticker ISR TO2
Status
Active
Order book id
199374
Amount of instruments
8 239 377
Currency
SEK
Trading period
10 Jul 2020 - 16 Nov 2021
Terms
One (1) warrant of series TO 2 entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of the volume-weighted average payment price for the Company's shares on the Nasdaq First North Growth Market during ten (10) trading days before the exercise period begins, from October 25, 2021 until November 5, 2021. However, the subscription price can not be lower than SEK 2.90. The exercising period with the support of warrants of series TO 2 will take place from November 9, 2021 until November 23, 2021.
Update (17.06.2020): Conversion of paid subscribed units (BTU) into shares and warrants of series TO 1 and TO 2.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.90 SEK
09 Nov - 23 Nov 2021
Option exercise terms for ISR TO2
People
Stig Ola Winqvist
CEO
Anders Milton
Chairman of the board
Hans Olof Glise
Board member
Gunnar Jardelöv
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Rörstrandsgatan 58
Zip code
113 40
City/district
Stockholm
Country
Sweden (SE)
Registration number
559026-7828
LEI code
5493007QQ16K1NL2PW55
First trade date
24 Mar 2017
Company former names
Natalz AB
30 Sep 2015
Goldcup 11680 AB
17 Sep 2015
Registration date
31 Aug 2007
Short name
ISR

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More